Danielle Joy Antalffy

Managing Director and Senior Equity Analyst at UBS Asset Management Americas Inc.

Danielle Joy Antalffy is a Managing Director and Senior Equity Analyst at UBS Investment Bank specializing in healthcare and medical technology, with an emphasis on the coverage of companies such as Tandem Diabetes Care, Senseonics Holdings, Dexcom, Insulet, and Edwards Lifesciences. Over her career, she has issued more than 700 stock ratings, maintaining a 50–52% success rate and generating average returns of 2.7–5.8%, with standout calls such as a 469% return on Senseonics Holdings. Antalffy joined UBS in 2022 after serving as Managing Director at Leerink Partners (2008–2022) and holding earlier analyst roles at Bear Stearns and Janney Montgomery Scott, following her undergraduate studies at the University of Pennsylvania. She holds professional credentials including registration with FINRA and relevant securities licenses, earning recognition for consistent performance and sector expertise.